Studies indicate that any reduction in metabolic rate during GLP-1 treatment is primarily attributable to: Decreased body mass : A smaller body naturally requires less energy for basic physiological functions Loss of metabolically active tissue : Both fat and lean tissue contribute to resting energy expenditure Normal adaptive thermogenesis : The body's natural response to caloric restriction and weight loss Comparative studies examining GLP-1-induced weight loss versus equivalent weight loss through diet and exercise show similar metabolic adaptations, suggesting the medications do not cause additional metabolic suppression beyond what would be expected with weight loss by any means
Ipamorelin is not FDA-approved for any indication and remains a research-only compound
Biochem J 347:8217, PMID: 10769188 Pineda-Molina E, Klatt P, Vzquez J, Marina A, Garca de Lacoba M, Prez-Sala D, Lamas S (2001) Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding
The investigators proposed that -AR upregulation might contribute to heightened lipolytic sensitivity in adipocytes
At JYM Supplement Science, we are committed to delivering an unmatched level of service that sets the standard in the industry
Cecilia Scott focuses on helping you understand how the treatment works, what to expect during the first few weeks, and how to prepare your body with proper hydration and balanced nutrition for a smooth start